CMV reactivation was significantly more common in patients with acute and chronic GVHD and the HLA antigens HLA-B14, HLA-DRB1*01, and HLA-DRB1*13, while it was significantly less common in patients with HLA-A11 and HLA-DRB1*04. Here, HLA-DRB1 is linked to graft versus host disease.